ETOMIDATE INJECTION, USP
ETOMIDATE INJECTION, USP
Approved
DIN Number
02537508
Drug Class
Human
Market Date
Jul 3, 2024
Company
HC
fresenius kabi canada ltd
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02537508
AIG Number0162234001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N01AX07 ETOMIDATE
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification28:04.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
ETOMIDATEActive
Strength: 2 MG / ML
Monograph: ETOMIDATE